Danska elitforskare belönas

Totalt 45 forskare får dela på 12 miljoner vid årets utdelning av det danska Eliteforskpriset. Ett av årets stora EliteForskpris går till en ung hjärnforskare som forskar kring Alzheimers sjukdom och hjärnskador.

Hårt tryck på Läkemedelsverket

Alltför många vill ansöka om Sverige som referensland i den decentraliserade processen för att godkänna läkemedel. Idag införs nya rutiner för att hantera situationen.

Han blir Alphahelix nya VD

Bolagets tidigare teknikchef tar ett steg upp.

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten Drejer, CEO of Symphogen. Ph.D.

First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.

Lytix calls in cash

Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Swedish Medtech söker ekonom/jurist

View pathology images in your iPhone

The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.

Elekta gets ok from China

The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.

New faces in Pronova Biopharma team

The Norwegian company Pronova Biopharma has recently changed the management team structure.

Control of blood vessels can treat obesity

Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet.

Orion cuts 205 jobs

The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recognized as good ones: in 2008, he was awarded the Eric K. Fernström Foundation's Prize for young researchers. It isn't the first award for the Associate Professor at Gothenburg University's Sahlgrenska Academy. In 2007, he received a grant award of 16 million SEK from the European Research Council for his pioneering work.